Novartis AG ( NVS) Q4 2010 Earnings Call January 27, 2011 8:00 am ET Executives Joseph Jimenez - CEO Jon Symonds - CFO David Epstein - Head of Pharma Jeff George - Head of Sandoz George Gunn - Head of Consumer Health Andrin Oswald - Head of Vaccines and Diagnostics Trevor Mundel - Head of Exploratory Clinical Development Susanne Schaffert - Global Head of IR Analysts Tim Race – Deutsche Bank Graham Parry - Bank of America/Merrill Lynch Andrew Baum - Morgan Stanley Matthew Weston - Credit Suisse Kevin Wilson - Citigroup Tim Anderson - Sanford Bernstein Carl Hancock - Hellvia Fabian Wenner - UBS Alexandra Hauber - JPMorgan Florent Cespedes Exane - BNP Paribas Alistair Campbell - Berenberg Bank David Evans - UT Credit PresentationOperator
Good morning or good afternoon, depending where you are attending from. I am Stephanie, the conf-call operator for this conference. Welcome to the Novartis Q4 and Full-Year 2010 Results conference call and live webcast. Please note that for the duration of the presentation, all participants will be in a listen-only mode and the conference is being recorded. After the presentation, there will be an opportunity to ask questions. (Operator Instructions). At this time, I would like to turn the conference over to Mr. Joe Jimenez. Please go ahead, sir. Joe Jimenez And I would like to welcome you all to our 2010 results conference call. Joining me today on the Novartis Center Jon Symonds, our CFO; David Epstein, Head of Pharma; Jeff George, Head of Sandoz, George Gunn, Head of Consumer Health and Andrin Oswald, Head of Vaccines and Diagnostics.